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Abstract 1 
Activation induced cytidine deaminase is an enzyme crucial to somatic 2 
hypermutation and gene conversion, processes that are essential for the 3 
diversification of Ig V genes. The bovine Ig repertoire appears to be diversified 4 
by mechanisms that are significantly different to those that operate in humans, 5 
and mice. This study set out to test the hypothesis that differences in the 6 
organisation, coding sequence, expression or genomic location of the bovine 7 
AICDA gene enables the encoded enzyme to catalyse the unusual Ig 8 
diversification mechanism seen in cattle as well as conventional antigen-driven 9 
mutation. Characterisation of bovine AICDA excluded the first two possibilities. 10 
AICDA expression was detected in lymphoid tissues from neonatal and older 11 
cattle, but AICDA cDNA could not be detected in muscle tissue.  The pattern of 12 
gene expression did not therefore differ from that in other vertebrates. The 13 
AICDA cDNA was cloned and expressed successfully in Escherichia coli generating 14 
a phenotype consistent with the mutating action of this deaminase.  Using a 15 
whole genome radiation hybrid panel, bovine  AICDA was mapped to a region of 16 
bovine chromosome 5 syntenic with the location of human AICDA on chromosome 17 
12. We conclude that the unusual nature of Ig diversification in cattle is unlikely 18 
to be attributable to the structure, sequence, activity or genomic location of 19 
bovine AICDA. 20 
 21 
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1. Introduction 1 
 2 
B lymphocytes that have undergone rearrangement at the Ig loci are able to 3 
carry out three further types of DNA modification reaction, depending on the 4 
host species and the environment in which the cell exists: class switch 5 
recombination (CSR) (Min and Selsing, 2005), somatic hypermutation (SHM) (Di 6 
Noia and Neuberger, 2007) and, notably in chickens, gene conversion (GC) 7 
(Ratcliffe, 2006). 8 
 9 
While different parts of the Ig loci may be altered in these reactions, all three 10 
modification processes share a fundamental dependence upon the enzyme 11 
activation induced cytidine deaminase (AID).  The gene encoding AID, AICDA, 12 
was first identified by subtractive cDNA hybridization studies of a murine 13 
lymphoma line under conditions designed to induce CSR (Muramatsu et al., 14 
1999).  The cDNA was recognised as coding for a member of the cytidine 15 
deaminase family which includes apolipoprotein B mRNA editing catalytic 16 
polypeptide 1 (APOBEC-1), APOBEC-2, and phorbolin.  APOBEC-1 is a well-17 
characterized RNA editing enzyme that recognizes the structure of the mRNA 18 
substrate through a cofactor, APOBEC-1 complementation factor.  This binds to 19 
the mRNA and allows the deaminase activity of APOBEC-1 to act upon its target 20 
cytidine (Mehta et al., 2000).  AID possesses a putative catalytic domain that is 21 
near-identical to that of APOBEC-1. 22 
  23 
The importance of AID to the antibody response has been shown in a great many 24 
studies.  For example, CSR is abolished in transgenic mice that carry mutations 25 
in AICDA and there is severe reduction of SHM (Muramatsu et al., 2000).  All 26 
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human patients with hyper IgM syndrome type 2 carry mutations in AICDA (Revy 1 
et al., 2000), and all these mutated AICDA cDNAs are defective in CSR, as 2 
determined by in vitro assays (Ta et al., 2003).  In cells that do not naturally 3 
express AICDA such as fibroblasts (Okazaki et al., 2002) and hybridomas (Martin 4 
and Scharff, 2002),  activation of the enzyme was shown to induce isotype 5 
switching or mutation events on artificial constructs or the endogenous 6 
rearranged Ig loci.  In the chicken B cell line DT40, AICDA disruption completely 7 
blocked Ig GC (Arakawa et al., 2002) and constitutive activation of the gene led 8 
to uncontrolled GC (Harris et al., 2002).  9 
 10 
In cattle, rearrangement per se generates little Ig diversity owing to the limited 11 
number of Ig segments that can be recruited to the process and their high 12 
degrees of sequence similarity (Berens et al., 1997; Sinclair et al., 1997).  Cattle 13 
are therefore reliant upon diversification processes that take place post-14 
rearrangement.  The mechanism and tissue location in which these processes 15 
occur remain elusive. It has been suggested that Ig diversification in cattle might 16 
parallel events in sheep, a species in which SHM in the ileal Peyer’s patches is 17 
thought to diversify the Ig repertoire early in life  (Jenne et al., 2006).  SHM in 18 
this context must differ in its regulation or basic mechanism from antigen-driven 19 
events in the germinal centres of lymph nodes. Our study set out to test the 20 
hypothesis that the organisation, coding sequence, expression or genomic 21 
location of the AICDA gene in cattle differs with respect to other animals and 22 
that these differences contribute to diversification and antigen-driven SHM of Ig 23 
V genes in cattle.  24 
 25 
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2. Materials and Methods 1 
 2 
2.1 Tissue samples 3 
Samples of liver, spleen, mesenteric lymph node, thymus, and muscle were 4 
collected post mortem from a Holstein Friesian cross calf one day after birth and 5 
from three calves that were 13 weeks old.  Animals were euthanized by 6 
barbiturate overdose by a qualified veterinary surgeon working within current UK 7 
legislation for animal welfare. At the time of collection, tissue samples were 8 
stabilised in RNAlater (Ambion) and stored at -80ºC.  Samples were used for 9 
extraction of genomic DNA (DNeasy tissue kit, Qiagen) and RNA (RNeasy midi kit, 10 
Qiagen). 11 
 12 
2.2 PCR amplification and partial cloning of AICDA gene 13 
To recover of sections of the bovine AICDA gene, PCR primers were designed 14 
from the high degree of conservation of human, mouse, chicken, dog and 15 
zebrafish AICDA cDNA sequences. Sequences of AICDA cDNA from these animals 16 
were aligned and primers were designed using DNAStar Lasergene software. The 17 
sequences of oligonucleotides used in these experiments are given in Table 1.  18 
As described below, the majority of the AICDA gene was recovered in a reaction 19 
with primers AID F6 and AID R5 (Figure 1). A separate reaction (AID F1 and AID 20 
R4) recovered an overlapping section of the gene extending to the 3’ region 21 
(Figure 1). 22 
 23 
A touchdown PCR method was used to amplify sequences predicted to form the 24 
central region of the bovine AICDA gene (Figure 1). Bovine genomic DNA was 25 
used as template with primes AID F6 and AID R5 primers (Figure 1; Table 1). 26 
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After initial denaturation at 95°C for 5 min, product was amplified over 35 1 
cycles.  The initial five cycles used conditions of 95°C for 1 min, 64ºC for 1 min, 2 
and 72°C for 3 min.  The annealing temperature was then reduced by 2ºC for 3 
each successive set of 5 cycles, the final 10 cycles of the reaction using an 4 
annealing temperature of 54ºC.  Incubation times remained fixed throughout.  5 
 6 
A conventional PCR protocol was used with primers AID F1 and AID R4 to recover 7 
the downstream region of the AICDA gene (Figure 1; Table 1).  This reaction used 8 
30 cycles of denaturation at 95°C for 40 sec, annealing at 58°C for 40 sec and 9 
extension at 72°C for 90 sec. 10 
 11 
This strategy enabled recovery of the majority of the bovine AICDA gene but 12 
comparison with other species suggested that an intron of significant size 13 
separated exons 1 and 2.  In addition, the first exon was expected to be very 14 
short preventing the design of a primer of sufficient length for recovery of the 15 
upstream section of the gene from genomic DNA. 16 
 17 
2.3 Recovery of full-length AICDA cDNA 18 
Total RNA was isolated from samples of bovine spleen using a commercial kit 19 
(RNeasy, Qiagen).  Contaminating DNA was removed from RNA preparations by 20 
treating with DNase (TURBO DNase enzyme, Ambion) and the quality and 21 
integrity of the isolated RNA was established by spectrophotometric comparison 22 
of the yields of 18S and 28S RNA species using an Agilent 2100 Bioanalyser 23 
(Agilent Technologies).  Final concentrations were measured by small-scale 24 
spectrophotometry with a NanoDrop-1000 instrument (NanoDrop Technologies).   25 
 26 
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First strand cDNA was synthesized by standard reverse transcription methods. A 1 
sample of 1µg of total RNA was added to a small 0.2 ml thin-walled PCR tube and 2 
the volume was made up to 11 µl with RNase-free water. To this, 1 µl of a 100 3 
µM stock of an oligo(dT) primer (sequence: 5' 4 
GGCCAGTGAATTGTAATACGACTCACTATAGGGAGA-(dT)24 3') was added and the 5 
contents of the tube were mixed and incubated at 70ºC for 10 min. The tube was 6 
centrifuged briefly and the following reagents were then added in succession: 4 7 
µl of 5x first strand buffer (Invitrogen), 2 µl of 0.1 M DTT, 1 µl of a 10 mM dNTP 8 
solution.  The contents were mixed, briefly centrifuged and incubated at 42ºC, 9 
pausing after 2 min to add 1µl of Superscript II reverse transcriptase (200U/µl; 10 
Invitrogen).  The incubation was continued for 1 hr, and then stopped by 11 
transfer to ice. 12 
 13 
A GenBank entry from the bovine genome project (accession no. NW_001001418) 14 
allowed the design of primers against non-coding sequences upstream of exon 1 15 
(AID exon 1F) and downstream of exon 5 (AID exon 5R).  Primer sequences are 16 
shown in Table 1.  Splenic cDNA was amplified with this primer pair using a 17 
conventional PCR protocol (initial denaturation at 94ºC for 2 min, and 30 cycles 18 
comprising denaturation at 94ºC for 1 min, annealing at 60ºC for 1 min and 19 
extension at 72ºC for 1min).  The products were reamplified with a nested 20 
primer set, AICDA cDNA F and AICDA cDNA R (Table 1).  By comparing sequence 21 
on the GenBank file NW_001001418 with the human AICDA gene, these primers 22 
were predicted to anneal at the termini of the AICDA reading frame.  The nested 23 
reaction was carried out with conventional PCR cycling conditions (initial 24 
denaturation at 94ºC for 2 min, and 30 cycles of comprising denaturation at 94ºC 25 
for 40 sec, annealing at 56ºC for 40 sec and extension at 72ºC for 1min). 26 
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 1 
2.4 Sequencing 2 
PCR products from genomic and cDNA amplifications were ligated into pCR-TOPO 3 
2.1 and pCR-TOPO XL vectors (Invitrogen), transformed into Escherichia coli, and 4 
after identification of recombinant clones, samples of plasmid DNA from 5 
independent clones were sequenced at the Sir Henry Wellcome Functional 6 
Genomics Facility, University of Glasgow.  The sequences were aligned, 7 
assembled and deposited at GenBank (accession no. DQ303466). The Bos taurus 8 
AICDA cDNA sequence was translated in silico and compared with the protein 9 
sequences from other species.  Sequence editing, alignments and phylogenetic 10 
analysis were performed using DNAStar Lasergene software. 11 
 12 
2.5 Expression of AICDA mRNA in bovine tissues 13 
Nested amplifications were carried out with AID F6 and AID R5 as an outer 14 
primer set and AID F2 with AID R2 as internal pair (Table 1).  cDNA samples 15 
prepared from spleen, lymph node, liver, muscle and thymus were used as 16 
templates.  As an internal control for the quality of each cDNA sample, GAPDH 17 
(GenBank accession NM_001034034) was amplified using primers from Endogen. 18 
 19 
2.6 Expression of AICDA in Escherichia coli  20 
The contribution of AID to SHM is founded upon the mutagenic activity of the 21 
deaminase. In E. coli, nucleotide substitutions in rpoB can generate rifampicin 22 
resistance but the rate at which these mutations arise spontaneously is low 23 
(Miller, 1972).  Petersen-Mahrt and colleagues showed that expression of human 24 
AICDA generated enhanced mutation frequency in E.coli leading to rifampicin 25 
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resistance (Petersen-Mahrt et al., 2002).  The experiments described here tested 1 
if the expression of bovine AICDA would have similar effects. 2 
 3 
In preparation for cloning into the pBAD/Myc-His vector (Invitrogen), cDNA was 4 
amplified with AID cDNA F (Nco I) and AID cDNA R (Spe I) (Table 1) to introduce 5 
Nco I and Spe I sites at the 5’ and 3’ termini of the amplicon.  After initial 6 
denaturation at 94ºC for 5 min, reactions were cycled 30 times through 94ºC (1 7 
min), 58ºC (30 sec) and 72ºC (30 sec) with a final incubation at 72ºC for 5 min.  8 
The PCR product was ligated into pCR-TOPO 2.1 and then subcloned into Nco I / 9 
Xba I cut pBAD/Myc-His-B using a Quick Ligation Kit (New England Biolabs).  This 10 
placed expression of AICDA under the control of the araBAD promoter. 11 
 12 
The recombinant plasmid was transformed into E. coli and expression was 13 
induced with 0.2% L-arabinose. The presence of recombinant protein was 14 
confirmed by SDS-PAGE and Western blotting using a mouse antibody to c-myc, a 15 
vector-encoded tag fused to the carboxy terminus of the bovine protein. 16 
Evidence for an elevation in mutation rate was sought by transforming E. coli 17 
with the pBAD vector or the recombinant construct carrying bovine AICDA.  After 18 
selection on LB agar containing ampicillin, individual clones were cultured in LB 19 
medium and induced with 0.2% L-arabinose for 4 hours or overnight.  Diluted 20 
aliquots from the cultures were then plated onto LB agar plates to determine 21 
the total number of bacteria, and to LB agar containing rifampicin (100 µg/ml). 22 
The number of rifampicin-resistant cells as a proportion of the total was then 23 
calculated. Data was compared between E. coli cultures carrying the pBAD 24 
vector and those with the AICDA expression construct and statistical significance 25 
assessed with the t test. 26 
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2.7 Physical mapping of bovine AICDA using a radiation-hybrid (RH) panel 1 
The chromosomal location of AICDA was sought by analysis of a cattle-hamster 2 
somatic hybrid panel, and a whole genome radiation cell hybrid panel (Womack, 3 
1997). The latter resource (WGRH5000) contains fragments of the bovine genome, 4 
generated by exposure of bovine cells to an x-ray dose of 5000 rad and rescued 5 
into stable lines by fusion with hamster cells. Lines carrying the AICDA gene 6 
were identified by PCR using primers AID (RH) F and AID (RH) R.  These spanned 7 
positions 8-30 and 111-130 of the AICDA cDNA sequence as derived in this study 8 
and were located on the gene’s second exon.  DNA from cells in the radiation 9 
hybrid panel was denatured at 95ºC for 15 min then amplified through 35 cycles 10 
of 94ºC for 30 sec, 58ºC for 30 sec and 72ºC for 45 sec.  A final extension step 11 
was performed at 72ºC for 10 min.  Once product had been confirmed from DNA 12 
samples from the cell hybrid panel, statistical analysis was carried out with the 13 
data (Chevalet and Corpet, 1986) to establish linkage with markers known to lie 14 
on particular chromosomes.  Two-point linkage analysis for AICDA was done with 15 
markers on the cattle WGRH5000 gene map (Band et al., 2000) using the software 16 
RHMAPPER 1.22 (Slonim et al., 1997).  This enabled an estimate to be made of 17 
the proximity of AICDA to other markers on its assigned chromosome. 18 
 19 
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3. Results 1 
 2 
3.1 Partial recovery of the Bos taurus AICDA gene 3 
A PCR strategy was designed to recover the majority of the bovine AICDA gene. 4 
This approach was attempted because of the high degree of conservation of 5 
human, mouse, chicken, dog and zebrafish AICDA cDNA sequences (Zhao et al., 6 
2005).  AID F6 was designed to anneal to bases 6353 to 6373 in exon 2 of the 7 
human gene (GenBank accession no. AB040430) and AID R5 was targeted to bases 8 
8468 to 8488 in exon 4.  Thus, based upon their binding to the human gene, AID 9 
F6 and R5 (Figure 1) were predicted to amplify a PCR product of around 2.1 kb 10 
from bovine genomic DNA.  In fact, PCR using genomic DNA from bovine liver as 11 
a template yielded a specific product of 3.4 kb (Figure 2).  A second PCR 12 
reaction was performed to recover the downstream regions of the gene using 13 
primers AID F1 and AID R4 (Figure 1).  AID F1 was predicted to anneal within 14 
exon 3 (bases 7814 to 7831 of the human gene) and AID R4 was designed from 15 
sequences in exon 5 (bases 8971 to 8994).  A PCR product of 1.5 kb was obtained 16 
as opposed to the 1.2 kb predicted from the human AICDA sequence.  The 17 
amplicons were cloned into TOPO vectors for sequencing.  The F1 / R4 product 18 
could be completely sequenced using primers that annealed to vector sites 19 
flanking the insert.  For the F6 / R5 product, a primer walking method was used 20 
to recover the complete sequence of the insert.  Data were assembled into a 21 
contig.  Since part of the gene from within exon 3 to part of exon 4 was present 22 
in both PCR products (Figure 1), a total of 4253 bases from the bovine AICDA 23 
gene were sequenced by this approach.  A partial structure for the bovine gene 24 
could be derived by comparing the data with the sequence of the human AICDA 25 
gene (Figure 3).  In summary, this revealed that the bovine gene shared with 26 
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multiple animal species a high degree of conservation of structure and protein 1 
coding sequences.  Although intron sequences were divergent and two of the 2 
three introns were substantially longer in the bovine gene than in its human 3 
orthologue (Figure 3), the data refute the hypothesis that the bovine AICDA gene 4 
is fundamentally different to orthologues from other species. 5 
 6 
Given the very small probable size of bovine exon 1 (8 nucleotides in human 7 
AICDA), the length of the intron separating exons 1 and 2 (5753 nucleotides in 8 
humans), and the divergence of intron sequences between bovine and human / 9 
mouse genes, it seemed unlikely that the same strategy would complete the 10 
characterisation of the bovine AICDA gene.  Given the high similarity in gene 11 
structure and exon sequences of bovine AICDA and genes from human, chicken 12 
and mouse (Arakawa et al., 2002; Muto et al., 2000), it seemed likely that the 13 
lengths of bovine AICDA exons 1 to 5 were 8, 148, 274, 116 and 54 bp 14 
respectively (Figure 3). 15 
 16 
3.2 Recovery of full length of AICDA cDNA 17 
To further assess if small but potentially significant differences existed between 18 
the AID proteins of cattle and other animals, the full length bovine cDNA was 19 
recovered and sequenced. To do this, data from a  BAC clone thought to carry 20 
the full AICDA sequence (GenBank accession no. NW_001001418) were analysed. 21 
Primers AID exon 1F and AID exon 5R were synthesised against  sequences 22 
predicted to comprise untranslated regions upstream of exon 1 and downstream 23 
of exon 5, respectively.  Nested primers (AID cDNA F and AID cDNA R) were 24 
based on homology of AICDA cDNAs from a range of species. PCR with these 25 
primers using  splenic cDNA yielded a 600 bp product which after sequencing and 26 
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annotation was deposited in GenBank (accession no. NM_001038682).  Analysis of 1 
the bovine AICDA cDNA sequence and comparison with genomic data revealed 2 
that the 600 nucleotides were derived from five exons as predicted (Figure 3), 3 
with exon 3 carrying one codon more than the human sequence.  The predicted 4 
protein sequence comprised 199 amino acids and was 94.4%, 93.9%, 90.9% and 5 
86.9% identical with dog, human, mouse and chicken sequences, respectively 6 
(Figure 4).  However, several differences of potential significance were noted.  7 
The bovine AID was predicted to carry a pair of lysine residues (residues 6 and 7) 8 
positioned closer to the amino terminus of the protein than equivalent residues 9 
(arginine / lysine or lysine / lysine) in the other mammalian enzymes (Figure 4).  10 
Bovine AID possessed a proline residue at position 39 that might disrupt the 11 
secondary structure of the protein in this region; alanine was present at this 12 
position in the other vertebrate AIDs represented in Figure 4, although pufferfish 13 
AID is known to carry proline in this location (Ichikawa et al., 2006).  Finally, the 14 
bovine AID contained an additional amino acid at position 118 (lysine; Figure 4).  15 
Other parts of the protein sequence were well-conserved, notably the cytidine 16 
deaminase motif and the carboxy-terminal leucine rich motif (Figure 4). 17 
Residues known to be critical for somatic hypermutation (Revy et al., 2000) were 18 
identical across the comparison (Figure 4) suggesting that the activity of the 19 
bovine AID protein was unlikely to differ substantially from that of enzymes 20 
found in the dog, mouse, human or chicken. 21 
 22 
3.3 Expression of AICDA mRNA in bovine tissues  23 
To assess for age dependence and tissue-specific expression of AICDA, cDNA was 24 
prepared from mesenteric lymph node, spleen, liver and muscle from day old 25 
and 13 week old cattle.  This was used as template to assess whether  AICDA 26 
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transcripts were present in the tissue samples.  In those reactions that were 1 
successful, a product of the predicted 131 bp emerged. The analysis (Figure 5) 2 
revealed the presence of AICDA transcripts in lymph node, spleen and thymus 3 
samples from a neonatal calf and animals 13 weeks of age.   There was no 4 
evidence of AICDA mRNA in muscle tissue (Figure 5).  Although the reaction was 5 
not conducted on a quantitative basis, yields of the PCR product were 6 
substantially lower from liver than from lymphoid cDNA suggesting transcript 7 
abundance was lower.  In contrast, the control reaction with primers against 8 
GAPDH was consistently successful and there was no visible difference in the 9 
amount of product (Figure 5). 10 
 11 
3.4 Expression of AICDA in Escherichia coli 12 
To assess if the predicted AID protein was stable and possessed the mutagenic 13 
properties that would be expected, the cDNA sequence was cloned into the E. 14 
coli expression vector pBAD/Myc-His.  Expression of a novel protein of 26 kDa 15 
was detected by SDS-PAGE and Western blotting following induction with L-16 
arabinose at 0.2% (data not shown).  This was consistent with the size predicted 17 
for AID (24 kDa) taking into account the vector-encoded detection and 18 
purification tags. 19 
 20 
E. coli TOP10 was transformed with pBAD/Myc-His and recombinant plasmid 21 
carrying AICDA cDNA.  After induction with 0.2% L-arabinose for 4 hours and 22 
overnight, conversion to rifampicin resistance was detected with a frequency 23 
that was 2-6 times higher than that of controls (ie E. coli  transformed with the 24 
pBAD vector lacking an insert).  The data are shown in Table 2. Variation in 25 
bacterial count meant that mean frequencies of rifampicin resistance did not 26 
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achieve statistically significant differences between test and control cultures (P 1 
<0.1, >0.05) but the data suggest that bovine AID had some mutagenic effect in 2 
the bacterial host. 3 
 4 
3.5 Chromosomal localisation of bovine AICDA 5 
A cattle-hamster somatic hybrid panel consisting of 31 cell line was screened by 6 
PCR with AICDA specific primers.  A statistically relevant concordance value of 7 
0.97 was obtained with the reference markers ACO2 and BM2830 (mitochondrial 8 
aconitase and a non-coding sequence tagged site). Both of these markers are 9 
known to be located on the distal half of bovine chromosome 5 (BTA5). This 10 
allowed the syntenic assignment of AICDA to BTA 5.  To refine the location of 11 
AICDA, PCR typing was used with the same primer sets using DNA from a cattle-12 
hamster WGRH5000 panel of 90 cell lines. The data from this analysis placed 13 
AICDA within 11.00 centriRay (cR5000) of the marker MAGP2 with a LOD score 14 
greater than 10.  One centriRay represents a separation that confers 1% 15 
probability that linkage between markers will break after exposure to 5000 rad 16 
of gamma radiation. MAGP2 is the gene encoding microfibril-associated 17 
glycoprotein 2. The predicted location of AICDA placed it close to M6PR, the 18 
gene for the mannose-6-phosphate receptor (Figure 6) although the proximity 19 
was not specifically estimated in these experiments. This assignment shows 20 
synteny with the location of human AICDA on chromosome 12.  21 
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4. Discussion 1 
 2 
This study characterized activation induced cytidine deaminase from B. taurus 3 
testing the hypothesis that differences in the organisation, coding sequence, 4 
expression or genomic location of the bovine AICDA gene might account for the 5 
unusual Ig diversification mechanism seen in cattle as well as conventional 6 
antigen-driven mutation.  7 
 8 
The cloning and sequencing of most of the gene was achieved through the design 9 
of homology primers and amplification from bovine genomic DNA.  The 10 
organisation of the gene was similar to that in mice and humans and the degree 11 
of sequence identity in the exons implied a high level of stability during 12 
mammalian evolution and beyond.  Although the chicken AICDA orthologue has a 13 
different gene structure (Figure 3), analysis of the cDNA has indicated that the 14 
coding sequence is remarkably similar to mammalian AICDA (Papavasiliou and 15 
Schatz, 2002).   AICDA genes from Xenopus gene (Zhao et al., 2005), fugu, 16 
catfish and zebrafish (Ichikawa et al., 2006; Zhao et al., 2005) show more 17 
widespread change but despite this, the zebrafish enzyme retained the ability to 18 
catalyse CSR when transfected into mouse B cells (Barreto et al., 2005).   19 
 20 
Recovery and analysis of the bovine AICDA cDNA revealed an open reading frame 21 
encoding 199 amino acid residues and a predicted protein sequence that was 22 
highly conserved and especially prominent within the cytidine deaminase motif 23 
which has been shown to be important for the activity of AID (Papavasiliou and 24 
Schatz, 2002).  There were two differences of note.  Many  AID  proteins 25 
including those distant from the mammalian enzymes (Ichikawa et al., 2006) 26 
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possess a cluster of basic residues at the amino terminus of the protein in a 1 
region predicted to form an alpha helix (Prochnow et al., 2007; Xie et al., 2004).  2 
This feature appeared to be shifted nearer to the amino terminus of the bovine 3 
enzyme.  Secondly, the bovine AICDA gene carried an additional codon in exon 3 4 
coding for lysine.  This was located in a part of the protein sequence that is 5 
widely conserved across a wide range of vertebrates but  AID  from fugu, 6 
zebrafish and catfish also possess an additional amino acid at this position 7 
(Ichikawa et al., 2006; Zhao et al., 2005).  There is no evidence that the 8 
additional amino acid present in this region in some species leads to a 9 
fundamental alteration in AID activity but the structural impact is presently 10 
unknown.  11 
 12 
The contribution of different regions of the AID protein to its function has been 13 
investigated via mutational analysis.  For example, it has been shown that 14 
deletion and mutation in the carboxy-terminal domain of AID uncoupled CSR 15 
from SHM and GC (Barreto et al., 2003; Ta et al., 2003).  Likewise, studies of the 16 
amino-terminus of AID have been identified mutations that impact upon SHM 17 
activity but not CSR (Shinkura et al., 2004).  Both regions of the bovine AID 18 
sequence are conserved when compared to other mammals. This refutes the 19 
hypothesis that the unusual nature of Ig diversification in cattle can be 20 
attributed to the properties of AID.   21 
 22 
The expression of AICDA mRNA in a range of bovine tissues showed  similarities 23 
to that reported for dogs and humans.  In these species, AICDA mRNA has been 24 
shown to be present in both lymphoid and, more surprisingly, in some non-25 
lymphoid tissues.   For example, AICDA expression has been detected in canine 26 
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thymus, lungs, liver, small intestine and kidneys as well as in lymphoid tissues 1 
(Ohmori et al., 2004).  In humans, strong expression was detected in lymph 2 
nodes and tonsils and at a lower level in thymus, kidney, pancreas and other 3 
tissues examined (Muto et al., 2000).  Members of Honjo’s laboratory 4 
(Muramatsu et al., 1999) have reported that AICDA transcripts were present in 5 
mouse bone marrow at a level almost comparable to that seen in spleen.  In our 6 
study of Bos taurus, AICDA transcripts were readily detectable in lymphoid cDNA 7 
preparations, were recovered at much lower yields from bovine liver, and could 8 
not be detected in muscle tissues.  Given that the assay was based upon a 9 
nested PCR reaction, it is possible that the low yield of AICDA amplicons from 10 
liver cDNA could have arisen from activated B cells in the samples, en route 11 
between lymphoid organs.  Since high-sensitivity, nested PCR was used, another 12 
explanation for the apparent presence of AICDA transcripts in the liver and 13 
thymus would be that RT-PCR is detecting very low level ectopic expression of 14 
AICDA.  15 
  16 
Radiation hybrid mapping placed the bovine AICDA gene on BTA5.  In humans, 17 
AICDA is located on chromosome 12 (HSA12).  Regions of synteny have been 18 
identified between BTA5 and HSA12 though other regions of the bovine 19 
chromosome bear genes located on HSA22 (Liu et al., 2003; Everts-van der Wind 20 
et al., 2004).  Comparative mapping studies of some regions of the human and 21 
bovine genomes have revealed substantial similarity in the presence and order of 22 
markers on several chromosomes (Everts-van der Wind, 2005) but for BTA5 and 23 
HSA12, multiple internal rearrangements seem to have occurred during 24 
evolution. However, our studies do not support the notion that an unusual 25 
 Page 19 
genomic location impacts upon AICDA function in cattle, another potential 1 
trigger to Ig diversification.   2 
 3 
The development of the bovine Ig system is incompletely understood, the most 4 
important deficiency being uncertainties of how, where and when Ig 5 
diversification takes place.  By analogy with other vertebrates, SHM and GC are 6 
the most likely mechanisms for creation of Ig diversity (Zhao et al., 2006).  Work 7 
with sheep (Jenne et al., 2006) and rabbits (Mage et al., 2006) has shown the 8 
importance of the gut associated lymphoid tissues - the ileal Peyer’s patches 9 
(IPP) in sheep and the appendix in rabbits – in Ig diversification.  Although there 10 
are many similarities between the Ig systems of sheep and cattle, important 11 
distinctions have also been noted (Zhao et al., 2006).  Thus, it is far from clear 12 
whether the IPP serves as the site for Ig diversification in Bos taurus.  Our 13 
studies have been unable to identify properties of bovine AICDA that might 14 
explain these differences, but our analysis may facilitate better assessment of 15 
events in the IPP of cattle. The characterisation of AICDA from the rabbit (Yang 16 
et al., 2005) illustrates the potential of this approach. 17 
 18 
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Figure legends 1 
 2 
Figure One.  Strategy for partial recovery of bovine AICDA by PCR 3 
A predicted structure of the bovine AICDA gene is shown, boxes indicating exons 4 
(roman numerals) and lines indicating introns.  The model was based upon the 5 
known structure of AICDA orthologues from other vertebrates.  Primers AID F6 and 6 
AID R5 were used for isolation of the central region of the bovine AICDA gene.  AID 7 
F1 and AID R4 were used to recover 3’ sequences. Primer sequences are shown in 8 
Table 1.  9 
 10 
Figure Two.  Amplification of the central region of the bovine AICDA gene with 11 
primers AID F6 and R5 12 
PCR was carried as described in the main text and reaction products were analysed 13 
on a 1% agarose gel with TAE buffer.  Lane 1 – PCR product of 3412 base pairs 14 
recovered from bovine genomic DNA using primers AID F6 and R5.  Lane 2 - 15 
negative control from which genomic DNA was omitted.  Lane 3 - 1 kb DNA ladder 16 
(Promega). 17 
 18 
Figure Three.  Experimentally-determined organisation of AICDA genes in a 19 
range of vertebrate species 20 
The organisation of AICDA genes in Bos taurus, human, mouse and chicken. Exons 21 
are represented by boxes, introns are represented by lines. For bovine AICDA, 22 
numbers in the shaded boxes indicate exon size in bp, and Roman numerals above 23 
each box show the exon number for all species. Introns are represented by lines, 24 
and the length of each intron in bp is shown above each line for the bovine and 25 
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human genes to allow comparison. Grey toning is used to indicate that exons 2 and 1 
5 of bovine AICDA could not be recovered completely by PCR.  Exon 3 of bovine 2 
AICDA contained 3 extra bases as compared to the human gene but otherwise exon 3 
sequence was highly conserved. For bovine AICDA, exon 1 is unfilled and intron 1 is 4 
dotted to indicate that their sizes were not determined experimentally.  The 5 
structure of the mouse AICDA gene was established from data at GenBank 6 
(accession number NT_039353).  Genes are approximately centred upon the start of 7 
exon 3 in each case. 8 
 9 
Figure Four.  Alignment of AID protein sequences from cow, dog, mouse, human 10 
and chicken  11 
The sequences are compared to bovine AID, dots indicating amino acid identity, a 12 
dash to indicate where a gap was introduced into the alignment.  Where 13 
differences to bovine AID exist, amino acids are marked using the single letter 14 
code.  The cytidine deaminase motif is shaded.  Amino acids that are critical to 15 
AICDA mediated somatic hypermutation (Revy et al., 2000) are indicated with an 16 
arrowhead beneath the aligned sequences.  The double underlined sequence is a 17 
putative Nuclear Exporter Sequence (NES) and overlaps with a conserved domain, 18 
important for CSR (McBride et al., 2004). 19 
 20 
Figure Five.  Expression of AICDA mRNA in bovine tissue 21 
PCR reactions were carried out with cDNA from tissues (indicated) from calves of 22 
one day of age (panels 1 and 2) and 13 weeks (panels 3 and 4).  Primers were used 23 
for amplification of AICDA transcripts (upper panels) and GAPDH (lower panels).  24 
Reactions were analysed by agarose gel electrophoresis and for simplicity, the 25 
relevant area of each area of the gel is presented. 26 
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Figure Six.  Chromosomal assignment of bovine AICDA 1 
Primers AID (RH) F  and AID (RH) R were used with DNA from a whole genome 2 
radiation hybrid panel of cattle-hamster hybrids to determine the chromosomal 3 
location of bovine AICDA (Band et al., 2000).  The vertical line represents bovine 4 
chromosome 5 (BTA5). Numbers on the left of the line represent distances along 5 
BTA5 in centriRays (cR5000). One cR5000 represents a separation that confers 1% 6 
probability that linkage between markers will break after exposure to 5000 rad of 7 
gamma radiation. Abbreviations to the right of the line show framework markers 8 
for the chromosome. Many of the markers are non-coding and serve only as markers 9 
for BTA5 and reference points for the location of genes that can be assigned to this 10 
chromosome.  11 
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